LOW CONCENTRATION DIMETHYL SULFOXIDE (DMSO) MODULATES EPILEPTIFORM SYNCHRONIZATION IN THE 4-AMINOPYRIDINE IN VITRO MODEL.

4-aminopyridine dimethyl sulfoxide entorhinal cortex ictal discharges

Journal

Journal of neuroscience methods
ISSN: 1872-678X
Titre abrégé: J Neurosci Methods
Pays: Netherlands
ID NLM: 7905558

Informations de publication

Date de publication:
17 Aug 2024
Historique:
received: 19 06 2024
revised: 14 08 2024
accepted: 16 08 2024
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 19 8 2024
Statut: aheadofprint

Résumé

Dimethyl sulfoxide (DMSO) is commonly used to dissolve water-insoluble drugs due to its dipolar and aprotic properties. It also serves as a vehicle in many pharmacological studies. However, it has been reported that DMSO can induce seizures in human patients, lower seizure threshold in vivo, and modulate ion receptors activities in vitro. Therefore, we investigated here the effect of 0.03% and 0.06% DMSO, which are 10 to 50 times lower than what usually employed in previous studies, in the 4-aminopyridine (4AP) model of epileptiform synchronization in male mouse brain slices. We found that 0.03% and 0.06% DMSO increase 4AP-induced ictal discharge rate, while 0.06% DMSO decreases ictal discharge duration. Our results suggest that the effects of DMSO on neuronal excitability deserve further analysis and that investigators need to be aware of its confounding effect as a solvent, even at very low concentrations.

Identifiants

pubmed: 39159871
pii: S0165-0270(24)00200-0
doi: 10.1016/j.jneumeth.2024.110255
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110255

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fei Ran Li (FR)

Montreal Neurological Institute-Hospital and Departments of Neurology & Neurosurgery and McGill University, 3801 University Street, Montréal, Québec H3A 2B4, Canada; Department of Physiology, McGill University, 3801 University Street, Montréal, Québec H3A 2B4, Canada.

Mia Gemayel (M)

Department of Psychology, McGill University, 2001 McGill College Ave, Montreal, Quebec, H3A 1G1.

Maxime Lévesque (M)

Montreal Neurological Institute-Hospital and Departments of Neurology & Neurosurgery and McGill University, 3801 University Street, Montréal, Québec H3A 2B4, Canada.

Siyan Wang (S)

Montreal Neurological Institute-Hospital and Departments of Neurology & Neurosurgery and McGill University, 3801 University Street, Montréal, Québec H3A 2B4, Canada.

Camila Franco Suarez (CF)

Department of Psychology, McGill University, 2001 McGill College Ave, Montreal, Quebec, H3A 1G1.

Massimo Avoli (M)

Montreal Neurological Institute-Hospital and Departments of Neurology & Neurosurgery and McGill University, 3801 University Street, Montréal, Québec H3A 2B4, Canada; Department of Physiology, McGill University, 3801 University Street, Montréal, Québec H3A 2B4, Canada. Electronic address: massimo.avoli@mcgill.ca.

Classifications MeSH